Gonorrhea in Women: Symptoms, Testing and Treatment in India

• Gonorrhea is caused by the bacterium Neisseria gonorrhoeae and is the second most common bacterial STI worldwide after chlamydia.
• Around half of cervical infections in women cause no symptoms, and throat and rectal infections are almost always silent.
• It is fully curable, but rising antibiotic resistance means the modern first-line treatment is an intramuscular ceftriaxone injection, not an oral tablet.
• It frequently travels with chlamydia, so testing and treatment usually cover both infections together.
• Free, confidential testing and treatment are available at NACO Designated STI/RTI Clinics in every district in India.
• Untreated gonorrhea can cause pelvic inflammatory disease, infertility, ectopic pregnancy and, in newborns, a serious eye infection.

Gonorrhea is an infection caused by the bacterium Neisseria gonorrhoeae. It infects the moist lining cells of the cervix, urethra, rectum, throat and, in newborns, the eyes. It spreads through unprotected sexual contact and does not survive long outside the body, so you cannot catch it from toilet seats, towels, swimming pools or shared utensils.

In India, gonorrhea is found in roughly one to four percent of women attending general STI clinics, with higher rates in some high-risk groups. National surveillance through NACO suggests the case burden is relatively stable; the bigger worry is that the bacterium is steadily becoming resistant to antibiotics. It also commonly travels alongside Chlamydia in Indian Women: Symptoms, Testing and Treatment — the two infections occur together in roughly a fifth to two-fifths of cases — which is why testing and treatment usually cover both.

The reason gonorrhea matters out of proportion to its often-mild symptoms is the same as for chlamydia: a silent infection can climb from the cervix into the fallopian tubes, cause pelvic inflammatory disease, and lead to blocked tubes, infertility and ectopic pregnancy. Gonorrhea can also occasionally enter the bloodstream and cause a more widespread illness, and it can infect a baby's eyes during birth.

There is also a great deal of stigma attached to gonorrhea — the old slang 'the clap' carries a sense of shame that is completely out of step with the medical reality. This is an ordinary, treatable bacterial infection. Acquiring it says nothing about your character, and you have every right to test and treat it without judgement.

Gonorrhea passes from one person to another through unprotected sexual contact with someone who carries it. The main routes are:

Because the bacterium prefers the lining of the cervix rather than the vaginal walls, it does not usually cause the vaginal soreness or itching seen with thrush or trichomoniasis. Throat and rectal infections are particularly important because they rarely cause symptoms, so they can be passed on unknowingly and act as quiet reservoirs.

Condoms used correctly and from the start of sexual contact reduce gonorrhea transmission substantially — by roughly 80 to 90 percent for vaginal and anal sex. Female (internal) condoms offer similar protection and put control with the receptive partner, and barriers during oral sex lower throat-infection risk. Spermicides do not protect against gonorrhea.

A mother with untreated gonorrhea at the time of a vaginal birth can pass the infection to her baby's eyes, causing a serious infection called ophthalmia neonatorum. This is the reason all Indian newborns receive protective eye drops or ointment shortly after birth.

About half of cervical gonorrhea infections in women cause no symptoms at all, and even when symptoms appear they are often mild and mistaken for something else. This is the main reason gonorrhea spreads silently and damages tubes over time.

When symptoms do show up, they usually appear two to ten days after exposure and can include:

Pain or burning when you pass urine is easily mistaken for a urinary tract infection, and an unusual discharge can be confused with other common causes — our guide to normal versus abnormal vaginal discharge can help you tell the difference. Because the signs overlap so much, testing is the only reliable way to know.

Throat infections from oral sex almost never cause a sore throat. Rectal infections may cause anal itching, discharge, bleeding or discomfort, but are frequently silent too. In a small number of cases (around 1 to 3 percent), the bacterium spreads into the bloodstream and causes fever, painful joints that move from one joint to another, and small skin spots — a more serious illness that needs hospital treatment.

Gonorrhea has a remarkable ability to evolve, and it has gradually become resistant to almost every antibiotic ever used against it — penicillin, tetracyclines, the fluoroquinolones (ciprofloxacin, ofloxacin), and the older oral option cefixime. Many of the single tablets that worked for decades no longer reliably cure the infection, and global health bodies have removed them from first-line treatment.

Because of this, the WHO, the US CDC and India's NACO now recommend an intramuscular injection of ceftriaxone as the cornerstone of treatment. The dose was raised from the historical 250 mg to 500 mg precisely because surveillance shows the bacterium creeping towards resistance, and the higher dose buys time. The injection is quick, well tolerated, and is given at any STI clinic or OB-GYN practice.

The practical message for women in India is simple: if you have heard that 'a single tablet cures gonorrhea', that advice is out of date. Insisting on a tablet-only treatment for convenience risks the infection persisting — still damaging your body and still transmissible. Trust the injection-plus-tablet protocol your provider follows.

Researchers are working on new antibiotics and even a possible vaccine to stay ahead of resistance, but none of these has yet replaced ceftriaxone in everyday Indian practice. Protecting the antibiotics we still have — by treating correctly and completing the course — is part of why getting proper care matters.

The most accurate test for gonorrhea is a nucleic acid amplification test (NAAT), which detects the bacterium's DNA with very high accuracy. It can be run on a vaginal swab (the preferred sample for women, and one you can often self-collect), an endocervical swab, a urine sample, or rectal and throat swabs if relevant. Results usually take one to three days.

In most situations a combined chlamydia-gonorrhea NAAT is the sensible test, because the two infections so often occur together. At private labs in India this combined test typically costs around ₹1,200 to ₹3,000, and many labs now offer home sample collection. A broader STI panel that adds HIV, syphilis and hepatitis runs higher. Our detailed breakdown of STI testing costs and where to test anonymously in India compares the options.

Free, confidential testing and treatment are available at NACO-supported Designated STI/RTI Clinics (DSRCs) in district hospitals and many primary health centres across India. These clinics also include HIV testing as standard, because the infections share transmission routes. Older laboratory methods such as Gram stain alone are far less reliable in women, so ask whether NAAT is available.

Who should get tested, and how often? Sexually active women under 25, and older women with a new or multiple partners, benefit from routine annual screening. Women on HIV pre-exposure prophylaxis (PrEP) are usually screened every three months. Anyone planning a pregnancy can reasonably include STI screening in their pre-conception checks.

The current first-line treatment for uncomplicated gonorrhea in women is a single intramuscular injection of ceftriaxone 500 mg, plus oral doxycycline 100 mg twice daily for seven days to cover possible chlamydia co-infection. This follows WHO, CDC and NACO guidance, and at NACO DSRCs everything — injection and tablets — is provided free.

In private practice, the ceftriaxone vial costs only ₹50 to ₹200, with administration and the doxycycline course bringing the total to roughly ₹300 to ₹1,000. Both you and your partner should complete treatment and avoid sex for seven days afterwards, so the infection is not simply passed back and forth.

Some situations need a tailored approach:

A routine 'test of cure' is not needed for ordinary genital gonorrhea treated with ceftriaxone, because cure rates are very high and the test can stay falsely positive for weeks as it picks up dead bacterial DNA. A test of cure is advised for throat infections, for any non-ceftriaxone alternative regimen, and whenever symptoms persist. Separately, everyone treated should be retested at three months, because reinfection from an untreated partner is common.

Left untreated, gonorrhea can cause a series of complications that make early detection worthwhile. The most important is pelvic inflammatory disease (PID), which develops when the infection climbs into the womb and tubes. Gonococcal PID often causes more dramatic symptoms than chlamydial PID — higher fever and more severe pain — but the lasting tubal damage is similar.

That tubal scarring is what links repeated infections to infertility. A single episode of PID leaves roughly one in eight women with damaged tubes; repeated episodes raise the risk steeply, and the chance of an ectopic pregnancy rises sharply too. If you are struggling to conceive after a past infection, our guide to fertility tests for women explains what assessment involves.

Less common but serious complications include a disseminated (bloodstream) infection with fever, joint pain and skin spots; a Bartholin gland abscess; and Fitz-Hugh-Curtis syndrome, where pelvic infection irritates the lining around the liver and causes upper-abdominal pain. Gonorrhea also inflames the genital lining in a way that makes HIV easier to acquire.

In newborns, untreated maternal gonorrhea can cause a severe eye infection within days of birth that, if not treated promptly, can damage sight. This is why every Indian baby receives protective eye drops or ointment after delivery.

Gonorrhea in pregnancy carries extra risks, including infection of the membranes, premature rupture of the waters, preterm birth and infection after delivery, as well as the risk to the baby's eyes during a vaginal birth. These risks justify a lower threshold for testing during pregnancy.

India's NACO programme mandates HIV and syphilis screening for every pregnant woman, but gonorrhea and chlamydia are not part of routine antenatal screening — they have to be specifically requested. If you have any risk factors (a new partner during pregnancy, a past STI, symptoms, or concerns about a partner), ask your obstetrician to add a combined chlamydia-gonorrhea NAAT, available free at DSRCs.

Treatment in pregnancy is a ceftriaxone 500 mg injection (safe in all trimesters) plus azithromycin 1 g by mouth for chlamydia cover, with a test of cure a few weeks later because persistent infection at delivery has real consequences. Treating the mother before birth removes the risk to the baby entirely.

Regardless of the mother's status, every Indian baby receives newborn eye protection — usually povidone-iodine eye drops or erythromycin ointment within an hour of birth. This is a routine part of newborn care, and parents do not need to arrange anything. If a mother is known to have gonorrhea at delivery, the baby is also given a dose of antibiotic and watched closely.

Treating yourself is only half the job — your sexual partner (or partners) also needs testing and treatment, otherwise the infection simply bounces back. Because gonorrhea now needs an injection, the 'give your partner a course of tablets' shortcut used for chlamydia does not work well here, so the goal is to get partners into a clinic. NACO DSRCs will test and treat any partner who comes in, free of charge.

For a married woman in India, the conversation can be genuinely hard. Partners are often the original source even when a woman is blamed, and stigma keeps many people from testing until complications force the issue. A clinic counsellor can help you find neutral wording — for example, framing it as a routine check the doctor has recommended — and our piece on how to talk about consent and sex within marriage explores these conversations further.

None of this is your fault, and you are not obliged to accept moral judgement from anyone, including a healthcare provider. Choosing a NACO DSRC or a younger, sexual-health-focused gynaecologist, and bringing a trusted person with you, can make the experience far easier.

If disclosing to a partner could put you at risk of violence, your safety comes first. A counsellor can help with anonymous partner notification or safety planning, and you can reach the national women's helpline 181 or a Sakhi One Stop Centre in any district. Our resources on recognising marital coercion and care after sexual assault offer further support.

Prevention rests on three things: barrier protection during sex, periodic screening to catch silent infection early, and prompt partner treatment when an infection is found. Together these substantially lower both your own risk and onward spread.

Condoms are the most effective everyday measure. Male condoms are cheap and widely available in India — free through NACO programmes and from ₹1 to ₹30 per condom in pharmacies — and female (internal) condoms give the receptive partner control. Used consistently and from the very start of contact, they cut transmission sharply. Barriers during oral sex matter too, given how silently the throat can carry infection.

Periodic screening is the safety net for the infections you cannot feel. Annual chlamydia-gonorrhea testing is sensible for sexually active women under 25 and for older women with new or multiple partners, and three-monthly testing is standard for women on PrEP. A wider look at STI screening for women puts gonorrhea in context alongside other common infections.

A newer preventive idea — taking doxycycline shortly after unprotected sex (doxy-PEP) — reduces some bacterial STIs in high-risk groups, but the evidence in heterosexual women is limited and it is not yet routine practice in India. If you think you might benefit, discuss it with a sexual-health-focused clinician rather than self-medicating.

See a doctor or visit a NACO STI clinic promptly if you notice any of the warning signs below, if you have had unprotected sex with a new partner, or if a partner tells you they have been diagnosed with an STI — even if you feel completely well, because gonorrhea is so often silent.

Seek urgent care for fever with severe pelvic pain, or for fever combined with painful, swollen joints and skin spots, as these can signal PID or a bloodstream infection that needs immediate treatment. If you are pregnant and develop any unusual discharge, bleeding or pelvic pain, contact your obstetrician without delay.

• WHO — Guidelines for the management of symptomatic sexually transmitted infections / gonorrhoea treatment
• CDC — Sexually Transmitted Infections Treatment Guidelines 2021: Gonococcal Infections
• WHO — Gonorrhoea (Neisseria gonorrhoeae infection) fact sheet)
• National AIDS Control Organisation (NACO), India — STI/RTI services and guidelines
• NHS — Gonorrhoea